A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer’s Disease: A Mini-Review
Gerontology
Fecha de publicación: January 2018
DOI: https://doi.org/10.1159/000485381
Autores: Van Skike C.E., Galvan V.
Background: Cerebrovascular dysfunction is detected prior to the onset of cognitive and histopathological changes in Alzheimer’s disease (AD). Increasing evidence indicates a critical role of cerebrovascular dysfunction in the initiation and progression of AD.
